Indication

Type 1 diabetes mellitus

Type 1 diabetes mellitus is a chronic autoimmune metabolic disorder characterized by the targeted destruction of insulin-producing beta cells in the pancreatic islets of Langerhans, resulting in absolute or near-absolute insulin deficiency. Read more about Type 1 diabetes mellitus

154 drugs 18 manufacturers

Advertisement

Drugs that treat it

Common Type 1 diabetes mellitus therapies.

Showing 100–108 of 154 drugs

Filter & compare in the drug finder →Opens the drug finder with Type 1 diabetes mellitus preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Type 1 diabetes mellitus.

Type 1 diabetes mellitus is a chronic autoimmune metabolic disorder characterized by the targeted destruction of insulin-producing beta cells in the pancreatic islets of Langerhans, resulting in absolute or near-absolute insulin deficiency.

Although it most frequently presents during childhood or adolescence, it can develop at any age.

Pathophysiologically, the disease involves genetic susceptibility and circulating islet-related autoantibodies that trigger immune-mediated insulitis.

This progressive loss of endogenous insulin leads to sustained hyperglycemia, altered carbohydrate, lipid, and protein metabolism, and an elevated risk of acute life-threatening complications such as diabetic ketoacidosis, alongside long-term microvascular and macrovascular pathology.

Personalize your experience

Follow Type 1 diabetes mellitus and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it